K

Kotra Industries Bhd
KLSE:KOTRA

Watchlist Manager
Kotra Industries Bhd
KLSE:KOTRA
Watchlist
Price: 4.42 MYR -1.56% Market Closed
Market Cap: 655.5m MYR
Have any thoughts about
Kotra Industries Bhd?
Write Note

Kotra Industries Bhd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kotra Industries Bhd
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
K
Kotra Industries Bhd
KLSE:KOTRA
Total Liabilities & Equity
myr344.1m
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
3%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Total Liabilities & Equity
myr115.1m
CAGR 3-Years
1%
CAGR 5-Years
10%
CAGR 10-Years
11%
A
Apex Healthcare Bhd
KLSE:AHEALTH
Total Liabilities & Equity
myr1.1B
CAGR 3-Years
20%
CAGR 5-Years
14%
CAGR 10-Years
13%
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Total Liabilities & Equity
myr229.2m
CAGR 3-Years
7%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Total Liabilities & Equity
myr543.5m
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
6%
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Total Liabilities & Equity
myr1.4B
CAGR 3-Years
5%
CAGR 5-Years
8%
CAGR 10-Years
20%
No Stocks Found

Kotra Industries Bhd
Glance View

Market Cap
655.5m MYR
Industry
Pharmaceuticals

Kotra Industries Bhd.is an investment holding company, which engages in the manufacturing and trading of pharmaceutical and healthcare products. The company is headquartered in Malacca, Melaka and currently employs 660 full-time employees. The company went IPO on 2000-10-30. The Company, through its subsidiary, Kotra Pharma (M) Sdn. Bhd, is engaged in pharmaceutical and healthcare products manufacturing and trading business. Its segments include Malaysia, Asia and Africa. Its products include Appeton Multivitamin Pastilles, which is a healthy chewable pastille (non-sugar coated) for children; Axcel Glimepiride Medication, which is used to treat diabetes mellitus type 2; Axcel Bromhexine (Children) Syrup, which is a mucolytic medicine used in the treatment of respiratory chest congestion; Arite Beclometasone 50mcg (Metered Dose Inhaler Product), which is used in long-term management of asthma; Vaxcel Granisetron Injection, which is an antiemetic to treat nausea and vomiting following chemotherapy and radiotherapy, and Axcel Atenolol, which is used to treat high blood pressure and heart-associated chest pain.

KOTRA Intrinsic Value
4.62 MYR
Undervaluation 4%
Intrinsic Value
Price
K

See Also

What is Kotra Industries Bhd's Total Liabilities & Equity?
Total Liabilities & Equity
344.1m MYR

Based on the financial report for Sep 30, 2024, Kotra Industries Bhd's Total Liabilities & Equity amounts to 344.1m MYR.

What is Kotra Industries Bhd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
3%

Over the last year, the Total Liabilities & Equity growth was 0%. The average annual Total Liabilities & Equity growth rates for Kotra Industries Bhd have been 8% over the past three years , 7% over the past five years , and 3% over the past ten years .

Back to Top